Ronald A Jordan

Title: The Innovations of Ronald A. Jordan

Introduction

Ronald A. Jordan is a notable inventor based in Richboro, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target central nervous system disorders. With a total of 2 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Jordan's latest patents include "Glucuronide metabolites and epimers thereof of tigecycline" and "Dihydrobenzofuran derivatives and uses thereof." The first patent identifies a glucuronide metabolite of tigecycline and its corresponding epimer, which have been found in humans treated with the drug. Mass spectral data were utilized to identify these structures. The second patent describes compounds that act as agonists or partial agonists of the 2C subtype of brain serotonin receptors. These compounds are useful for treating various central nervous system disorders, including schizophrenia.

Career Highlights

Jordan has had a distinguished career, working at Wyeth, a prominent pharmaceutical company. His research and innovations have contributed to advancements in drug development and therapeutic applications.

Collaborations

Some of his notable coworkers include William DeMaio and Matthew Hoffmann, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Ronald A. Jordan's contributions to the field of pharmaceuticals through his patents and research have made a significant impact on the treatment of central nervous system disorders. His work continues to influence the development of innovative therapeutic solutions.